Treatment of Diversion Colitis with Short-Chain-Fatty Acid Irrigation

Abstract

A condition known as diversion colitis frequently develops in segments of the colorectum after surgical diversion of the fecal stream; it persists indefinitely unless the excluded segment is reanastomosed. The disease is characterized by bleeding from inflamed colonic mucosa that mimics the bleeding of idiopathic inflammatory bowel disease, and it may culminate in stricture formation. We hypothesized that this condition is caused by the absence of luminal short-chain fatty acids, the preferred metabolic substrates of colonic epithelium. We studied four patients with diversion colitis, none of whom had evidence of Crohn's, idiopathic ulcerative, or infectious colitis. The excluded segment of the rectosigmoid contained negligible concentrations of short-chain fatty acids. When D-glucose was instilled, it did not undergo appreciable anaerobic fermentation. Instillation of a solution containing short-chain fatty acids twice daily resulted in the disappearance of symptoms and the inflammatory changes observed at endoscopy, over a period of four to six weeks. Remission has been maintained for up to 14 months (in one patient) by instillation daily to twice weekly. Administering enemas containing isotonic saline, or omitting treatment for periods of two to four weeks during the regimen, by contrast, did not produce any improvement or rapid relapse of the colitis. Histologic observation revealed a distinctive type of mucosal inflammation that resolved more slowly and less completely than the gross appearance of the inflamed mucosa. From these preliminary studies we infer that diversion colitis may represent an inflammatory state resulting from a nutritional deficiency in the lumen of the colonic epithelium, which is effectively treated by local application of short-chain fatty acids, the missing nutrients.

Histone deacetylase inhibitors modulates the induction and expression of amphetamine-induced behavioral sensitization partially through an associated learning of the environment in mice

“…BA does not have any reported effects on the GABAergic system. BA is used as an effective treatment in a wide range of human diseases, including cancers, β-thalassemia and bowel inflammatory pathologies [14,25,31]. Thus, VPA and BA differ in many aspects of their pharmacological actions, but share the common molecular action of HDAC inhibition.…”

High-level expression of IkB-b in the surface epithelium of the colon: in vitro evidence for an immunomodulatory role

“…Activation of IL-8 expression is significantly diminished in Caco-2 cells after spontaneous differentiation by growth to a post-confluent state or after treatment with compounds that inhibit cell proliferation and induce markers of a differentiated phenotype such as vitamin D and sodium butyrate [12]. The effect of butyrate on IL-8 gene expression was of particular interest to us because indirect evidence suggests that it may normally play an important role in modulating the immune response of the colonic mucosa [14][15][16][17][18][19][20]. The only tissue in vertebrates that is normally exposed to substantial levels of butyrate is the mucosa of the colon through the fermentation of carbohydrates by the normal colonic bacterial flora [21,22].…”

Cell type‐ and promoter‐dependent modulation of the Wnt signaling pathway by sodium butyrate

“…The short-chain fatty acid sodium butyrate, a possible therapeutic differentiating agent, [23][24][25][26][27] has been linked to changes in gene expression, which lead to growth arrest, differentiation and/or apoptosis. 28 -36 Butyrate has been shown to stimulate these processes in a number of cell lines, including colonic carcinoma cells.…”